Evidence map›Paper›PMID 36559069›Full record

ArticlePharmaceutics2022

Influence of Hydrophobic Side-Chain Length in Amphiphilic Gradient Copoly(2-oxazoline)s on the Therapeutics Loading, Stability, Cellular Uptake and Pharmacokinetics of Nano-Formulation with Curcumin.

Shubhashis Datta, Veronika Huntošová, Annamária Jutková, Róbert Seliga, Juraj Kronek, Adriána Tomkova, Lenka Lenkavská, Mariana Máčajová, Boris Bilčík, Barbora Kundeková and 5 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shubhashis DattaCenter for Interdisciplinary Biosciences, Technology and Innovation Park, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.ORCID 0000-0001-6322-4261
Veronika HuntošováCenter for Interdisciplinary Biosciences, Technology and Innovation Park, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.ORCID 0000-0003-0042-2097
Annamária JutkováDepartment of Biophysics, Faculty of Science, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.ORCID 0000-0002-0833-8511
Róbert SeligaCenter for Interdisciplinary Biosciences, Technology and Innovation Park, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.
Juraj KronekDepartment for Biomaterials Research, Polymer Institute of the Slovak Academy of Sciences, Dubravska Cesta 9, 845 41 Bratislava, Slovakia.
Adriána TomkovaDepartment of Biophysics, Faculty of Science, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.
Lenka LenkavskáDepartment of Biophysics, Faculty of Science, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.
Mariana MáčajováInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska Cesta 9, 840 05 Bratislava, Slovakia.ORCID 0000-0002-4034-6001
Boris BilčíkInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska Cesta 9, 840 05 Bratislava, Slovakia.ORCID 0000-0002-9933-5147
Barbora KundekováInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska Cesta 9, 840 05 Bratislava, Slovakia.
Ivan ČavargaInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska Cesta 9, 840 05 Bratislava, Slovakia.
Ewa PavlovaInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovskeho Nam. 2, 162 06 Prague, Czech Republic.
Miroslav ŠloufInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovskeho Nam. 2, 162 06 Prague, Czech Republic.ORCID 0000-0003-1528-802X
Pavol MiškovskýCenter for Interdisciplinary Biosciences, Technology and Innovation Park, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.
Daniel JancuraDepartment of Biophysics, Faculty of Science, P. J. Safarik University in Košice, Jesenna 5, 04154 Košice, Slovakia.

Funding

Open scientific community for modern interdisciplinary research in medicine (Acronym: OPENMED), ITMS2014+: 313011V455 supported by the Operational Programme Integrated Infra-structure, the project Building-up Centre for advanced materials application of t ITMS project code 313021T081Slovak Research and Development Agency and Slovak Grant Agency VEGA 1/0156/18, VEGA 2/0042/21, VEGA 2/0172/21, APVV-15-0485, and APVV-20-0202
6 · The paper itself

Abstract

Due to the simple one-step preparation method and a promising application in biomedical research, amphiphilic gradient copoly(2-oxazoline)s are gaining more and more interest compared to their analogous block copolymers. In this work, the curcumin solubilization ability was tested for a series of amphiphilic gradient copoly(2-oxazoline)s with different lengths of hydrophobic side-chains, consisting of 2-ethyl-2-oxazoline as a hydrophilic monomer and 2-(4-alkyloxyphenyl)-2-oxazoline as a hydrophobic monomer. It is shown that the length of the hydrophobic side-chain in the copolymers plays a crucial role in the loading of curcumin onto the self-assembled nanoparticles. The kinetic stability of self-assembled nanoparticles studied using FRET shows a link between their integrity and cellular uptake in human glioblastoma cells. The present study demonstrates how minor changes in the molecular structure of gradient copoly(2-oxazoline)s can lead to significant differences in the loading, stability, cytotoxicity, cellular uptake, and pharmacokinetics of nano-formulations containing curcumin. The obtained results on the behavior of the complex of gradient copoly(2-oxazoline)s and curcumin may contribute to the development of effective next-generation polymeric nanostructures for biomedical applications.

Indexed as

cancer cellscurcuminhydrophobicitypolymeric nanoparticlesstructure-property–relationship

Identifiers

PMID36559069
PMCPMC9781838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.